Guardian Pharmacy Services Inc. Class A Common Stock (GRDN)

About GRDN

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and grou…

Sector

Consumer Staples

Industry

Retail-Drug Stores and Proprietary Stores

Employees

3,600

Website

guardianpharmacy.com/

Fundamentals

1-day range

$36.84$37.61

Market cap

$2.58B

P/E (trailing)

45.91

P/E (forward)

25.92

EPS (trailing)

$0.82

Dividend yield

—

Beta

0.52

Avg. volume

393.7K

Forecasts

6 analyst ratings

Guardian Pharmacy Services Inc. Class A Common Stock Competitors

Chosen by industry and closest market cap.

• GRDN

  Guardian Pharmacy Services Inc. Class A Common Stock

  $37.09

  ▼ 0.64%
  Market cap $2.58BP/E 45.91
  $23.14$47.02
• PETS

  PetMed Express Inc. Common Stock

  $1.88

  ▲ 1.35%
  Market cap $42.32MP/E —
  $1.57$4.1
• YI

  111 Inc. American Depositary Shares

  $3.46

  ▼ 1.14%
  Market cap $31.82MP/E —
  $2.48$11.17
• CVS

  CVS Health Corporation Common Stock

  $93.07

  ▲ 0.16%
  Market cap $134.44BP/E 25.04
  $69.51$110.68

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Oppenheimer Maintains Outperform on Guardian Pharmacy Service, Raises Price Target to $49
  benzinga · 8/7/2026
• Oppenheimer Maintains Outperform on Guardian Pharmacy Service, Raises Price Target to $49
  Benzinga · 8/7/2026
• Guardian Pharmacy Services, Inc. (GRDN) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/7/2026
• Guardian Pharmacy Services (NYSE:GRDN) Beats Q2 EPS, Raises Full-Year Guidance
  ChartMill · 8/7/2026
• Guardian Pharmacy Service Q2 Adj. EPS $0.29 Beats $0.27 Estimate, Sales $351.768M Beat $340.045M Estimate
  Benzinga · 8/6/2026
• Guardian Pharmacy Service Raises FY2026 Sales Guidance from $1.400B-$1.420B to $1.430B-$1.450B vs $1.415B Est
  Benzinga · 8/6/2026

• Mary Sue Patchett · May 5, 2026 · Grant

  4.0K
• Steven D. Cosler · May 5, 2026 · Grant

  4.0K
• Randall J. Lewis · May 5, 2026 · Grant

  4.0K
• Pharmacy Investors, LLC · March 28, 2026 · Option Exercise

  1.41M
• William E. Bindley · March 28, 2026 · Option Exercise

  6.10M
• Thomas J. Salentine Jr. · March 28, 2026 · Option Exercise

  6.10M
• Kendall Forbes · March 28, 2026 · Option Exercise

  608.6K
• David K. Morris · March 28, 2026 · Option Exercise

  641.9K
• Bindley Capital Partners I, LLC · March 28, 2026 · Option Exercise

  6.10M
• John Ackerman · March 28, 2026 · Option Exercise

  471.1K
• John Ackerman · March 28, 2026 · Option Exercise

  1.41M
• Fred Burke · March 28, 2026 · Option Exercise

  1.30M
• Cardinal Equity Fund, L.P. · March 28, 2026 · Option Exercise

  471.1K
• David K. Morris · March 20, 2026 · Sale

  187.9K @ $29.68
• Pharmacy Investors, LLC · March 20, 2026 · Sale

  827.6K @ $29.68

Institutional Ownership

March 31, 2026

Total shares held

27.72M

Total value held

$988.68M

Institutional holders

162